Skip to main content
Premium Trial:

Request an Annual Quote

NIA Study Demonstrates ApoE's Potential as Blood-Based Protein Biomarker for Alzheimer's


In a National Institute on Aging-supported study released this week, Alzheimer's researchers found that levels of the protein apolipoprotein E in blood samples were strongly associated with levels of beta-amyloid deposits in the brain.

Because increased deposits of beta-amyloid are considered a hallmark of Alzheimer's, this link suggests that ApoE could be used as a blood-based protein biomarker for the disease.

In the study, which appeared in the online version of the Journal of Alzheimer's Disease in October and in this month's print edition, a team led by NIA scientist Madhav Thambisetty used mass spec to analyze the blood samples of 57 older, symptom-free subjects and compared those analyses to brain amyloid measurements of the same subjects taken via PET scans. The results demonstrated a strong correlation between the levels of amyloid plaques and levels of ApoE.

In a statement, Thambisetty said he now plans to test the results in serial blood samples collected from participants in the NIA's Baltimore Longitudinal Study of Aging to investigate how changing blood levels of ApoE may relate to pathological changes in the brain over time.

“If the results are equally positive, we may be able to develop a blood test that provides a less invasive, inexpensive method that helps to detect the early pathological changes of Alzheimer's disease,” he said.

This is not the only study to have examined a link between Alzheimer's disease and ApoE. The APOE gene, which makes the protein, is a known genetic risk factor for late-onset Alzheimer's. The protein was also one of the proteins examined as part of the Alzheimer's Disease Neuroimaging Initiative's effort to identify blood-based biomarkers for the disease. Results from that work were released earlier this month and are currently undergoing analysis (PM 12/10/2010).

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.